Omniome

OverviewSuggest Edit

Omniome operates as a biotechnology company. The company develops a proprietary DNA sequencing platform capable of delivering unsurpassed sequencing accuracy with the potential to advance cancer diagnostics, drive high fidelity single-cell applications, and broadly support clinical sequencing. 

TypePrivate
Founded2013
HQSan Diego, CA, US
Websiteomniome.com
Employee Ratings4

Latest Updates

Employees (est.) (Mar 2021)151
Cybersecurity ratingAMore

Key People/Management at Omniome

Robert Wicke

Robert Wicke

Chief Executive Officer and Director
Arnold Oliphant

Arnold Oliphant

Chief Technology Officer
Richard Shen

Richard Shen

Chief Product Officer
Kelly Perez

Kelly Perez

Chief Operating Officer
Karen Smith

Karen Smith

VP of People & Culture
Ken Song

Ken Song

MD Chairman
Show more

Omniome Office Locations

Omniome has an office in San Diego
San Diego, CA, US (HQ)
6965 Lusk Blvd
Show all (1)

Omniome Financials and Metrics

Summary Metrics

Founding Date

2013

Omniome total Funding

$120 m

Omniome latest funding size

$60 m

Time since last funding

a year ago

Omniome investors

Omniome's latest funding round in January 2020 was reported to be $60 m. In total, Omniome has raised $120 m
Show all financial metrics

Omniome Cybersecurity Score

Cybersecurity ratingPremium dataset

A

91/100

SecurityScorecard logo

Omniome Online and Social Media Presence

Embed Graph

Omniome News and Updates

Omniome Appoints Robert Wicke as Chief Executive Officer

SAN DIEGO, Nov. 20, 2020 /PRNewswire/ -- Omniome, Inc., developer of a novel DNA sequencing platform capable of delivering unsurpassed sequencing accuracy, today announces the appointment of Robert Wicke as Chief Executive Officer. He will immediately assume day-to-day leadership and join...

Omniome Appoints Richard Shen, Ph.D. As Chief Product Officer

SAN DIEGO, Sept. 29, 2020 /PRNewswire/ -- Omniome, Inc., developer of an innovative DNA sequencing platform capable of delivering unsurpassed sequencing accuracy, today announces the appointment of Richard Shen, Ph.D. as Chief Product Officer. Richard brings over 25 years' experience in...

Omniome Closes $60 Million Series C Financing To Advance Novel Genomic Sequencing Platform

SAN DIEGO, Jan. 9, 2020 /PRNewswire/ -- Omniome, Inc., developer of an innovative DNA sequencing platform capable of delivering unsurpassed sequencing accuracy, today announced it has raised an additional $60 million with the completion of its Series C financing. The funding round was led...

Omniome Completes $60 Million Series B Financing To Advance Novel Genomic Sequencing Technology

SAN DIEGO, July 30, 2018 /PRNewswire/ -- Omniome, Inc., developer of an innovative new DNA sequencing platform, today announced it has raised an additional $60 million with the completion of its Series B financing. The funding round was led by Decheng Capital and Hillhouse Capital Group,...

Omniome Blogs

OMNIOME APPOINTS ROBERT WICKE AS CHIEF EXECUTIVE OFFICER

Robert Wicke brings comprehensive leadership to innovative start-up SAN DIEGO- November 20, 2020- Omniome, Inc., developer of a novel DNA sequencing platform capable of delivering unsurpassed sequencing accuracy, today announces the appointment of Robert Wicke as Chief Executive Officer.  He will im…

Omniome Frequently Asked Questions

  • When was Omniome founded?

    Omniome was founded in 2013.

  • Who are Omniome key executives?

    Omniome's key executives are Robert Wicke, Arnold Oliphant and Richard Shen.

  • How many employees does Omniome have?

    Omniome has 151 employees.

  • Who are Omniome competitors?

    Competitors of Omniome include Vita 34, Organovo Holdings and BioGaia.

  • Where is Omniome headquarters?

    Omniome headquarters is located at 6965 Lusk Blvd, San Diego.

  • Where are Omniome offices?

    Omniome has an office in San Diego.

  • How many offices does Omniome have?

    Omniome has 1 office.